Binds to soluble TNF-alpha, but not to lymphotoxin (TNF beta). Adalimumab (Humira) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with rheumatoid arthritis, psoriatic arthritis,